Organization Overview
Historical Acquisition Tree
Alternative names
tafasitamab (Monjuvi) (2020 NDA)
Key: MorphoSys (7) Acquired (3)
Key: MorphoSys (9) Acquired (6)
Arthritis (Phase 2)
Arthritis, Rheumatoid (Phase 2)
Dermatitis (Phase 1)
Dermatitis, Atopic (Phase 1)
Glomerulonephritis (Phase 2)
Glomerulonephritis, Membranous (Phase 2)
Leukemia (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 2)
Leukemia, Prolymphocytic (Phase 2)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Non-Hodgkin (Phase 2)
Multiple Myeloma (Phase 2)
Multiple Sclerosis (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Prostatic Neoplasms (Phase 1)
Sclerosis (Phase 2)